Faculty Interview & Free CME/NCPD Activity: Graft-Versus-Host Disease

from Oncology Data Advisor · host i3 Health

Click here to claim CME/NCPD credit for this activity: https://i3health.com/oda-gvhd This audio includes both the additional updates interview and complete podcast from i3 Health’s CME/NCPD activity New Opportunities for Improved Patient Outcomes in Graft-Versus-Host Disease. First, listen along as Dr. Shernan Holtan shares the latest data from the BTM CTN 1703 trial of posttransplant cyclophosphamide, tacrolimus, and mycophenolate mofetil as GVHD prophylaxis after allogeneic hematopoietic cell transplantation, then stay tuned after the interview to listen along to the full activity.

Episode metadata supplied by the publisher feed · Published May 23, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Faculty Interview & Free CME/NCPD Activity: Graft-Versus-Host Disease

0:00 1:11:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Data Advisor?

This episode is 1 hour and 11 minutes long.

When was this Oncology Data Advisor episode published?

This episode was published on May 23, 2023.

Can I download this Oncology Data Advisor episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!